Rapamycin is used to prevent graft rejection in transplant recipients based on its ability to suppress T-cell proliferation. The drug blocks the activity of a protein known as mammalian target of ...

In vivo experimental findings have also shown that ketamine has an inhibitory effect in lipopolysaccharide (LPS)-induced microglial ... in CD4 + T-cells leads to mTOR activatiwhich is on ...